Literature DB >> 20037764

Cerebral vasomotor reactivity in epilepsy patients.

Semai Bek1, Tayfun Kaşikçi, Güray Koç, Gençer Genç, Seref Demirkaya, Zeki Gökçil, Zeki Odabaşi.   

Abstract

Vasomotor reactivity, which can be defined as the cerebral vasculature response to hypoxia, is not well known in epilepsy patients. We aimed to evaluate cerebrovascular reserve in idiopathic generalized epilepsy patients using transcranial Doppler ultrasonography (TCD). The study included 20 patients and 20 healthy volunteers. Diagnosis of epilepsy was based on the observation of seizure in the video electroencephalography unit. Cerebrovascular reactivity was evaluated by means of the breath-holding index. Insonation depth and basal velocity were symmetrical and not significantly different between the two groups (p[0.05). The breath-holding index ranged from 0.62 to 4.45 (mean 2.13 +/- 0.83) in the epilepsy patients and 0.57 to 2.55 (mean 1.60 +/- 0.46) in the control group (p\0.05). Breath-holding index values showed that cerebrovascular reserve in epilepsy patients was increased, as compared to healthy individuals. Cerebrovascular reserve was increased in epilepsy patients; this should not be accepted as an abnormality, but might have been the result of an adaptive mechanism that protects the brain from hypoxic challenges due to seizure apnea.

Entities:  

Mesh:

Year:  2010        PMID: 20037764     DOI: 10.1007/s00415-009-5428-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  34 in total

1.  Effects of the nitric oxide synthase inhibitor L-NMMA on cerebrovascular and cardiovascular responses to hypoxia and hypercapnia in humans.

Authors:  Kojiro Ide; Matthew Worthley; Todd Anderson; Marc J Poulin
Journal:  J Physiol       Date:  2007-08-02       Impact factor: 5.182

Review 2.  Adenosine augmentation therapies (AATs) for epilepsy: prospect of cell and gene therapies.

Authors:  Detlev Boison
Journal:  Epilepsy Res       Date:  2009-05-09       Impact factor: 3.045

3.  Estimation of cerebrovascular reactivity using transcranial Doppler, including the use of breath-holding as the vasodilatory stimulus.

Authors:  H S Markus; M J Harrison
Journal:  Stroke       Date:  1992-05       Impact factor: 7.914

4.  Partial seizures manifesting as apnea only in an adult.

Authors:  H W Lee; S B Hong; W S Tae; D W Seo; S E Kim
Journal:  Epilepsia       Date:  1999-12       Impact factor: 5.864

5.  Nitric oxide synthase inhibition in humans reduces cerebral blood flow but not the hyperemic response to hypercapnia.

Authors:  R P White; C Deane; P Vallance; H S Markus
Journal:  Stroke       Date:  1998-02       Impact factor: 7.914

6.  Changes in cerebral blood flow velocities during childhood absence seizures.

Authors:  R De Simone; M Silvestrini; M G Marciani; P Curatolo
Journal:  Pediatr Neurol       Date:  1998-02       Impact factor: 3.372

7.  Inhibition of nitric oxide synthase does not alter dynamic cerebral autoregulation in humans.

Authors:  Rong Zhang; Thad E Wilson; Sarah Witkowski; Jian Cui; Graig G Crandall; Benjamin D Levine
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-03       Impact factor: 4.733

8.  Cerebral vasomotor reactivity is reduced in patients with erectile dysfunction.

Authors:  Edoardo Vicenzini; Marta Altieri; Paolo Maria Michetti; Maria Chiara Ricciardi; Mauro Ciccariello; Hossein Shahabadi; Francesco Puccinelli; Gian Luigi Lenzi; Vittorio Di Piero
Journal:  Eur Neurol       Date:  2008-06-05       Impact factor: 1.710

9.  Long term follow-up of unilateral occlusion of the internal carotid artery including repeated tests of vasomotor reactivity by transcranial Doppler.

Authors:  Vera Zbornikova
Journal:  Neurol Res       Date:  2006-03       Impact factor: 2.448

10.  Decreased vasomotor reactivity in Alzheimer's disease.

Authors:  Soon-Tae Lee; Keun-Hwa Jung; Yong-Seok Lee
Journal:  J Clin Neurol       Date:  2007-03-20       Impact factor: 3.077

View more
  1 in total

1.  Cerebral vasomotor reactivity in epilepsy patients.

Authors:  Vijay K Sharma; Hock Luen Teoh; Bernard P L Chan
Journal:  J Neurol       Date:  2010-03-26       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.